CTT Pharmaceutical Holdings, Inc. (CTTH)
0.055
0.00 (0.00%)
USD |
OTCM |
Oct 22, 16:00
CTT Pharmaceutical Holdings EPS Diluted (Quarterly) : -0.0003 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0003 |
| March 31, 2026 | -0.0014 |
| December 31, 2025 | -0.0009 |
| September 30, 2025 | -0.0003 |
| June 30, 2025 | -0.0001 |
| March 31, 2025 | -0.0005 |
| December 31, 2024 | -0.0009 |
| September 30, 2024 | -0.0007 |
| June 30, 2024 | -0.002 |
| March 31, 2024 | -0.0012 |
| December 31, 2023 | -0.0001 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | -0.0002 |
| March 31, 2023 | -0.0005 |
| December 31, 2022 | -0.0014 |
| September 30, 2022 | 0.0004 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | -0.0001 |
| December 31, 2021 | 0.0002 |
| September 30, 2021 | 0.0016 |
| June 30, 2021 | -0.0023 |
| March 31, 2021 | -0.0023 |
| December 31, 2020 | -0.002 |
| September 30, 2020 | -0.0038 |
| June 30, 2020 | -0.003 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.0036 |
| December 31, 2019 | -0.0031 |
| September 30, 2019 | -0.0034 |
| June 30, 2019 | -0.0014 |
| March 31, 2019 | -0.0047 |
| December 31, 2018 | -0.0039 |
| September 30, 2018 | -0.0076 |
| June 30, 2018 | -0.0256 |
| March 31, 2018 | -0.0024 |
| December 31, 2017 | -0.0338 |
| September 30, 2017 | -0.0018 |
| June 30, 2017 | -0.0066 |
| March 31, 2017 | -0.0013 |
| December 31, 2016 | 0.0004 |
| September 30, 2016 | -0.01 |
| June 30, 2016 | -0.0118 |
| March 31, 2016 | -0.0098 |
| December 31, 2015 | -0.019 |
| September 30, 2015 | -0.0016 |
| June 30, 2015 | -0.017 |
| March 31, 2015 | -0.0173 |
| December 31, 2014 | 0.0139 |
| September 30, 2014 | -0.0027 |
| June 30, 2014 | -0.0198 |
| March 31, 2014 | -0.0308 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 0.0858 |
| Eli Lilly & Co. | 7.939 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.0152M |
| Total Expenses (Quarterly) | 0.0152M |
| Enterprise Value | 3.304M |
| Earnings Yield | -5.27% |
| Normalized Earnings Yield | -4.364 |